"canagliflozin" meaning in All languages combined

See canagliflozin on Wiktionary

Noun [English]

IPA: /ˌkæn.əɡ.ləˈfloʊ.zɪn/ [General-American]
Etymology: From cana- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”). Etymology templates: {{af|en|cana-|-gliflozin|nocat=1|qq1=of unknown origin|t2=sodium–glucose cotransporter inhibitor}} cana- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”) Head templates: {{en-noun|-}} canagliflozin (uncountable)
  1. (pharmacology) A drug C₂₄H₂₅FO₅S·½H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Invokana and when used in combination with metformin, under the trademark Invokamet. Wikipedia link: canagliflozin Tags: uncountable Categories (topical): Pharmaceutical drugs
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "cana-",
        "3": "-gliflozin",
        "nocat": "1",
        "qq1": "of unknown origin",
        "t2": "sodium–glucose cotransporter inhibitor"
      },
      "expansion": "cana- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From cana- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "canagliflozin (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -gliflozin",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Healthcare",
            "Fundamental",
            "Health",
            "Body"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A drug C₂₄H₂₅FO₅S·½H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Invokana and when used in combination with metformin, under the trademark Invokamet."
      ],
      "id": "en-canagliflozin-en-noun-rpZknvca",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "blood sugar",
          "blood sugar"
        ],
        [
          "reabsorption",
          "reabsorption"
        ],
        [
          "glucose",
          "glucose"
        ],
        [
          "kidney",
          "kidney"
        ],
        [
          "orally",
          "orally"
        ],
        [
          "metformin",
          "metformin"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A drug C₂₄H₂₅FO₅S·½H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Invokana and when used in combination with metformin, under the trademark Invokamet."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "canagliflozin"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌkæn.əɡ.ləˈfloʊ.zɪn/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "canagliflozin"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "cana-",
        "3": "-gliflozin",
        "nocat": "1",
        "qq1": "of unknown origin",
        "t2": "sodium–glucose cotransporter inhibitor"
      },
      "expansion": "cana- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From cana- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "canagliflozin (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms suffixed with -gliflozin",
        "English uncountable nouns",
        "Pages with 1 entry",
        "Pages with entries",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A drug C₂₄H₂₅FO₅S·½H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Invokana and when used in combination with metformin, under the trademark Invokamet."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "blood sugar",
          "blood sugar"
        ],
        [
          "reabsorption",
          "reabsorption"
        ],
        [
          "glucose",
          "glucose"
        ],
        [
          "kidney",
          "kidney"
        ],
        [
          "orally",
          "orally"
        ],
        [
          "metformin",
          "metformin"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A drug C₂₄H₂₅FO₅S·½H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Invokana and when used in combination with metformin, under the trademark Invokamet."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "canagliflozin"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌkæn.əɡ.ləˈfloʊ.zɪn/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "canagliflozin"
}

Download raw JSONL data for canagliflozin meaning in All languages combined (1.8kB)


This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2024-12-21 from the enwiktionary dump dated 2024-12-04 using wiktextract (d8cb2f3 and 4e554ae). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.